key: cord-0865880-xaz18zwr
authors: Park, Steven; Perlin, David S.; Fitzgerald, Sean; Petraitis, Vidmantas; Walsh, Thomas J.
title: Focused Multivector Ultraviolet (FMUV) Technology Rapidly Eradicates SARS-CoV-2 in-vitro: Implications for Hospital Disinfection of COVID-19 Environments
date: 2022-02-11
journal: Am J Infect Control
DOI: 10.1016/j.ajic.2022.02.001
sha: 545dfa0e4731a6a4d2f88ba4091474ce02d27076
doc_id: 865880
cord_uid: xaz18zwr

Focused Multivector Ultraviolet (FMUV) technology rapidly killed the SARS-CoV-2 coronavirus in-vitro. Plates were inoculated with a mean of greater than 10(6) plaque forming units (PFUs) of USA-WA1 Washington index patient strain of SARS-CoV-2 and exposed to ultraviolet, resulting in mean reductions of 99.99% within 30 seconds, 99.999% within 60 seconds, and 99.9999% within 90 seconds. The results support the effectiveness of FMUV technology for SARS-CoV-2 disinfection.

Hospitals worldwide have suffered the effects of the COVID-19 pandemic. Surface contamination by SARS-CoV-2 is a prevalent problem in hospitals caring for COVID-19 patients, 1 and has been noted as a potential source of transmission. 2 

Several studies have demonstrated the activity of ultraviolet-C (UV-C) against SARS-CoV-2. 3, 4, 5 However, the test conditions utilized do not easily translate to the hospital environment. UV instruments using a single lamp or centralized source of lamps lose microbicidal activity as an inverse function of the radial distance from the source (1/r 2 ), while also being limited by shadowing effects for three-dimensional surfaces. However, Focused

Multivector Ultraviolet (FMUV) systems sustain high UV-C energy levels in the exposure field and overcome shadowing by virtue of the technology's method of light delivery from multiple sources. FMUV has been previously shown as an automated approach for overcoming inconsistencies inherent to manual cleaning. 6 It was hypothesized that the technology being tested would rapidly eradicate SARS-CoV-2 in-vitro to document its efficacy for continued use in healthcare applications for environmental disinfection. Therefore, this study investigated the efficacy of FMUV for various exposure durations on a patient strain of SARS-CoV-2 in-vitro.

Discovery and Innovation according to strict biosafety guidelines.

A solution of the USA-WA1 Washington index patient strain of SARS-CoV-2 stock was prepared in accordance with ASTM E1053 standards 7 in Dulbecco's Modified Eagle Medium (DMEM) +2% Fetal Bovine Serum (FBS) with a titer of mean 1.125x10 6 PFU/mL for controls.

An FMUV system (PurpleSun Inc., New York) was deployed in a configuration to surround a 76x183cm test table centered in the rectangular-shaped target zone at a 74cm height ( Figure 1 ). This zone is typically designated for disinfection of critical patient care equipment as large as patient beds and operating tables. 6 

Glass slide carriers (25x75x1mm) were cleaned, sterilized, placed within sterile Petri dishes, and inoculated with a 0.1mL viral droplet. Due to BSL-3 safety and containment requirements, Petri CONFIDENTIAL dishes were covered with UV-transmissible material throughout the test, which were known to partially reduce UV exposure to the samples. Samples were exposed to FMUV light for durations of 0, 30, 45, and 90 seconds.

After exposure, viral droplets were extracted from their carrier using a P200 pipette with a sterile aerosol barrier tip, diluted by a factor of 10, and assayed for infectivity in VeroE6 cells in DMEM + FBS, supplemented with Penicillin, Streptomycin, and Amphotericin B. Cells were stained with 0.5% crystal violet, washed, and the detected number of viable organisms for each carrier was listed as plaque forming units (PFUs). Standard methods for data analysis and calculations were utilized to determine Log Reduction (LR) and Percent Reduction (PR). 8

Data from the plaque assay on virus infectivity at the given dilution is shown in Table 1 . detected PFUs, such as observed here. 9 However, this is addressed in the Data Analysis section of Environmental Protection Agency MB-31-03, which was therefore used to compute the results.

At a 10-fold dilution when a portion of carriers at a given time point showed zero, a value of 5 PFU/mL was used. The mean LR and PR was then calculated for the 30s and 45s time points.

The standard further describes, for time points where zero PFUs are observed for all treated carriers, the LR and PR are recorded as ≥ the mean log 10 density of the control carriers, which was followed for the 90s time point.

The germicidal activity of FMUV resulted in a mean 4-log reduction (99.9954%) of PFUs/carrier within 30 seconds, 5-log reduction (99.9994%) in 45 seconds, and ≥6-log reduction (≥99.9999%) in 90 seconds. Using the Aspin-Welch Test for Unequal Variance, p-values at all time points were 0.011, which is considered statistically significant.

This study demonstrated rapid in-vitro eradication of viable SARS-CoV-2 within 90 seconds. To our knowledge, this is the first study to demonstrate a ≥6-log reduction of viable SARS-CoV-2 in a large-scale test setup within 90s. One study reported a >6-log reduction after 540s of UV exposure using one lamp at a 3cm distance, 4 while another described a >3-log reduction after 84.4s also using one lamp at 25cm. 5 The system employed in this study has been utilized in a wide range of hospital settings for equipment disinfection, especially between patient cases. Although this system is designed to treat equipment, the deployment wall and any other surfaces that are within the target zone will also disinfected. As US hospitals become increasingly overwhelmed with variant COVID-19 cases, the need for rapid and effective disinfection is highlighted to properly facilitate safe patient room turnover. Though there is little in-vitro data on air disinfection of SARS-CoV-2 to date, pathogens are known to be more susceptible to UV-C in air than on surfaces or in liquid. 10 Furthermore, as this study demonstrated significant activity against the virus in-vitro suspended in a droplet on surfaces, the data suggests that this method of delivery would produce similar effects on aerosolized SARS-CoV-2 droplets.

This study demonstrates FMUV rapidly reduced the SARS-CoV-2 coronavirus by ≥99.9999% within 90 seconds. Coupled with this technology's ability to treat equipment without requiring users to evacuate the room, 6 this data identifies FMUV as a potentially important approach to controlling COVID-19 in healthcare environments.

Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients

An overview of research on air and environmental contamination with SARS-CoV-2 in healthcare settings

SARS-CoV-2 Survival on Surfaces and the Effect of UV-C Light

Susceptibility of SARS-CoV-2 to UV irradiation

UV-C irradiation is highly effective in inactivating SARS-CoV-2 replication

Comparative evaluation of operating room terminal cleaning by two methods: Focused multivector ultraviolet (FMUV) versus manual-chemical disinfection

ASTM E1053-20, Standard Practice to Assess Virucidal Activity of Chemicals Intended for Disinfection of Inanimate, Nonporous Environmental Surfaces

Procedure for the OECD Quantitative Method for Testing Antimicrobial Products against Spores of Clostridium difficile (ATCC 43598) on Inanimate, Hard, Nonporous Surfaces. Environmental Protection Agency

E2197 -17: Standard Quantitative Disk Carrier Test Method for Determining Bactericidal, Virucidal, Fungicidal, Mycobactericidal, and Sporicidal Activities of Chemicals

Ultraviolet Germicidal Irradiation Handbook: UVGI for Air and Surface Disinfection